Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Sources and Prices of Selected Medicines and Diagnostics for People Living with HIV/AIDS
(2005; 85 pages) View the PDF document
Table of Contents
View the documentGlossary
View the document1. Introduction
View the document2. Price information projects
View the document3. Paediatric formulations and diagnostics
View the document4. Access to quality HIV/AIDS medicines and diagnostics
View the document5. Prices of medicines and diagnostics
View the document6. List of manufacturers - Medicines and diagnostics
Open this folder and view contentsANNEX 1
Open this folder and view contentsANNEX 2
View the documentANNEX 3. Further reading, reference and contacts
Open this folder and view contentsANNEX 4. Untangling the web of price reductions: A pricing guide for the purchase of ARVs for developing countries
View the documentFeedback, application and corrections form
 

5. Prices of medicines and diagnostics

5.1 Medicines

TABLE 1. ANTI-INFECTIVE MEDICINES

 

Manufacturer

Indicative price, US$

List prices, US$

Anthelminthics - Antifilarials

No. of manufacturers

No. of countries

unit

max

min

median

25th perc

Brazil

Spain

crotamiton

                 

cream/lotion 10%

1

1

ml

0.010

0.010

0.010

0.010

n/a

0.877

ivermectin

                 

scored tablet, 3 mg

1

1

tablet

0.530

0.530

0.530

0.530

n/a

n/a

scored tablet, 6 mg*

-

-

tablet

-

-

-

-

n/a

n/a

lindane

                 

cream, lotion or powder, 0.3%

1

1

gram

0.122

0.122

0.122

0.122

n/a

n/a

permethrin

                 

cream, 5%

1

1

gram

0.152

0.152

0.152

0.152

n/a

0.175

lotion, 1%

1

1

ml

0.019

0.019

0.019

0.019

n/a

n/a

Anthelminthics - Intestinal anthelminthics

                 

albendazole

                 

chewable tablet, 400 mg

13

8

tablet

0.420

0.007

0.045

0.022

0.048

0.929

Antibacterials, beta lactam medicines

                 

benzathine benzylpenicillin

                 

powder for injection, 1.44 g (=2.4 million IU) in 5-ml vial

3

3

vial

1.300

0.170

0.278

0.224

n/a

n/a

benzylpenicillin

                 

powder for injection, 3 g (=5 million IU) (as sodium or potassium salt) in vial

3

2

vial

1.200

0.180

0.350

0.265

0.619

1.284

powder for injection, 600 mg (=1 million IU) (as sodium or potasium salt) in vial

2

2

vial

0.200

0.146

0.173

0.160

n/a

1.765

cefixime

                 

paediatric oral suspension, 100 mg/5 ml

2

2

ml

0.163

0.034

0.098

0.066

n/a

0.075

paediatric oral suspension, 40 mg/5 ml

1

1

ml

0.098

0.098

0.098

0.098

n/a

n/a

powder for injection, 250 mg (as sodium salt)*

-

-

vial

-

-

-

-

n/a

n/a

tablet, 200 mg

5

4

tablet

0.975

0.186

0.343

0.291

n/a

0.749

tablet, 400 mg

2

2

tablet

0.400

0.165

0.283

0.224

n/a

1.373

ceftriaxone

                 

powder for injection, 1 g (as sodium salt) in vial

18

10

1 g vial

4.613

0.109

1.170

0.900

0.687

6.237

powder for injection, 250 mg (as sodium salt) in vial

13

7

vial

2.917

0.270

0.700

0.470

n/a

1.840

powder for injection, 500 mg (as sodium salt) in vial

14

10

vial

3.664

0.085

0.800

0.700

n/a

3.462

procaine benzylpenicillin

                 

powder for injection, 1 g (=1 million IU) in vial

1

1

vial

0.134

0.134

0.134

0.134

n/a

n/a

powder for injection, 3 g (=3 million IU) in vial

2

2

vial

0.240

0.144

0.192

0.168

n/a

n/a

Antibacterials, others azithromycin

                 

oral suspension, 200 mg/5 ml (dihydrate)

4

2

ml

0.133

0.040

0.042

0.040

0.078

0.226

tablet/capsule, 250 mg (dihydrate)

7

3

tablet/capsule

0.890

0.117

0.152

0.121

n/a

n/a

tablet/capsule, 500 mg (dihydrate)

7

4

tablet/capsule

2.714

0.247

0.667

0.275

0.447

2.175

capreomycin1

                 

powder for injection, 1 g in vial

1

1

1 g vial

5.000

5.000

5.000

5.000

n/a

2.074

chloramphenicol

                 

capsule, 250 mg

3

3

capsule

0.028

0.014

0.020

0.017

n/a

n/a

oily suspension for injection, 0.5 g/ml (as sodium succinate) in 2-ml ampoule*

-

-

ampoule

-

-

-

-

n/a

n/a

oral suspension, 150 mg/5 ml (as palmitate)*

-

-

ml

-

-

-

-

n/a

n/a

powder for injection, 1 g (sodium succinate) in vial

5

3

1 g vial

1.440

0.175

0.280

0.231

0.371

n/a

ciprofloxacin

                 

tablet, 250 mg (as hydrochloride)

25

14

tablet

0.658

0.008

0.028

0.020

0.048

0.151

tablet, 500 mg (as hydrochloride)

24

12

tablet

1.289

0.013

0.044

0.034

0.058

0.295

clarithromycin

                 

oral suspension, 125 mg/5 ml*

-

-

ml

-

-

-

-

n/a

0.061

powder for injection, 500 mg

1

1

vial

0.700

0.700

0.700

0.700

n/a

11.105

tablet, 250 mg

14

9

tablet

0.472

0.105

0.160

0.133

0.296

0.582

clindamycin

                 

capsule, 150 mg

4

4

capsule

0.113

0.033

0.058

0.035

0.660

0.131

cream, 2% (as phosphate)

1

1

gram

0.125

0.125

0.125

0.125

n/a

n/a

injection, 150 mg/ml (as phosphate) in 2-ml ampoule

1

1

ampoule

2.008

2.008

2.008

2.008

0.464

1.206

cycloserine1

                 

capsule, 250 mg

1

1

capsule

0.466

0.466

0.466

0.466

n/a

n/a

doxycycline

                 

capsule/tablet, 100 mg (hydrochloride)

12

6

capsule/tablet

0.025

0.008

0.016

0.014

0.052

0.090

erythromycin

                 

powder for injection, 500 mg (as lactobionate) in vial*

-

-

vial

-

-

-

-

n/a

n/a

powder for oral suspension, 125 mg (as stereate or ethylsuccinate)

8

7

ml

0.977

0.006

0.011

0.009

0.010

n/a

tablet/capsule, 250 mg (as stearate or ethylsuccinate)

15

8

tablet/capsule

0.049

0.021

0.030

0.025

n/a

n/a

tablet/capsule, 500 mg (as stearate or ethylsuccinate)

12

7

tablet/capsule

0.090

0.043

0.051

0.047

0.099

0.162

gentamicin

                 

injection, 10 mg/ml (as sulfate) in 2-ml vial

1

1

vial

0.109

0.109

0.109

0.109

0.072

0.357

injection, 40 mg/ml (as sulfate) in 2-ml vial

4

3

vial

0.370

0.058

0.118

0.101

0.065

0.402

metronidazole

                 

injection, 500 mg in 100-ml vial

6

5

vial

2.880

0.570

0.700

0.651

0.189

2.434

oral suspension, 200 mg (as benzoate)/5 ml

6

5

ml

0.008

0.003

0.005

0.004

n/a

n/a

suppository, 1 g

1

1

suppository

0.450

0.450

0.450

0.450

n/a

n/a

suppository, 500 mg*

-

-

suppository

-

-

-

-

n/a

n/a

tablet, 200 mg

7

6

tablet

0.011

0.003

0.007

0.005

n/a

n/a

tablet, 500 mg

6

6

tablet

0.093

0.009

0.022

0.019

n/a

n/a

vaginal gel, 0.75%

1

1

gram

0.025

0.025

0.025

0.025

n/a

0.108

ofloxacin

                 

IV infusion, 2 mg/ml (hydrochloride)

2

2

ml

0.032

0.012

0.022

0.017

n/a

n/a

tablet, 200 mg

11

7

tablet

0.713

0.024

0.063

0.044

n/a

0.412

tablet, 400 mg

7

4

tablet

0.158

0.062

0.120

0.097

1.014

n/a

rifabutin

                 

capsule, 150 mg*

-

-

capsule

-

-

-

-

n/a

2.118

silver nitrate

                 

solution (eye drops), 1%*

-

-

ml

-

-

-

-

n/a

n/a

spectinomycin

                 

powder for injection, 2 g (as hydrochloride) in vial

1

1

vial

4.000

4.000

4.000

4.000

n/a

n/a

sulfadiazine

                 

injection, 250 mg (sodium salt) in 4-ml ampoule*

-

-

ampoule

-

-

-

-

n/a

n/a

tablet, 500 mg

3

3

tablet

0.324

0.041

0.149

0.095

0.018

0.060

sulfamethoxazole+trimethoprim

                 

injection, 80+16 mg/ml in 10-ml ampoule*

-

-

ampoule

-

-

-

-

n/a

n/a

oral suspension, 200+40 mg/5 ml

15

9

ml

0.149

0.003

0.005

0.003

0.002

0.012

tablet, 100+20 mg

7

5

tablet

0.015

0.001

0.007

0.004

n/a

0.021

tablet, 400+80 mg

21

13

tablet

0.027

0.005

0.010

0.008

0.016

0.039

tablet, 800+160 mg

13

8

tablet

0.066

0.011

0.018

0.014

0.069

0.098

Antifungal medicines

                 

amphotericin B

                 

IV infusion, powder for reconstitution 50 mg vial*

-

-

vial

-

-

-

-

n/a

133.166

liposomal IV infusion, 5 mg/ml in vial*

-

-

vial

-

-

-

-

n/a

0.584

powder for injection, 50 mg in vial

2

2

vial

9.000

3.664

6.332

4.998

2.426

1.910

clotrimazole

                 

cream, 1%

13

11

gram

0.133

0.009

0.026

0.016

0.653

1.194

pessary, 500 mg

2

2

pessary

0.600

0.400

0.500

0.450

n/a

1.619

fluconazole

                 

capsule, 150 mg

10

7

capsule

1.300

0.028

0.225

0.066

0.151

3.438

capsule, 200 mg

8

6

capsule

1.406

0.036

0.233

0.170

n/a

4.590

capsule, 50 mg

7

5

capsule

0.500

0.043

0.163

0.094

n/a

1.143

injection, 2 mg/ml in ampoule

4

3

ml

0.046

0.008

0.039

0.027

0.014

0.049

oral suspension, 50 mg/5 ml*

-

-

ml

-

-

-

-

n/a

0.234

itraconazole

                 

capsule, 100 mg

4

4

capsule

0.550

0.132

0.406

0.266

0.292

0.806

oral solution, 10 mg/ml*

-

-

ml

-

-

-

-

n/a

0.968

ketoconazole

                 

cream, 2%

7

7

gram

2.510

0.016

0.024

0.020

n/a

2.335

oral suspension, 100 mg/5 ml*

-

-

ml

-

-

-

-

n/a

n/a

tablet, 200 mg

13

10

tablet

0.188

0.006

0.040

0.032

n/a

0.426

miconazole

                 

cream/ointment 2% (as nitrate) 15 g tube

5

4

tube

0.700

0.258

0.455

0.380

n/a

n/a

cream/ointment 2% (as nitrate) 20 g tube

4

4

tube

1.357

0.200

0.545

0.410

n/a

n/a

cream/ointment 2% (as nitrate) 30 g tube

8

4

tube

0.980

0.026

0.490

0.438

0.618

1.918

cream/ointment 2% (as nitrate) 40 g tube

1

1

tube

0.669

0.669

0.669

0.669

n/a

1.792

nystatin

                 

lozenge, 100,000 IU

1

1

lozenge

0.030

0.030

0.030

0.030

n/a

n/a

pessary, 100,000 IU

6

5

pessary

0.030

0.019

0.024

0.022

n/a

0.093

tablet, 100,000 IU

4

3

tablet

0.025

0.017

0.023

0.020

n/a

n/a

tablet, 500,000 IU

9

6

tablet

0.075

0.028

0.040

0.036

n/a

0.061

Antiprotozoal medicines

                 

pentamidine

                 

powder for injection, 200 mg (isetionate) in vial

1

1

vial

9.000

9.000

9.000

9.000

n/a

n/a

powder for injection, 300 mg (isetionate) in vial

3

3

vial

48.400

5.020

24.700

14.860

36.948

7.039

pyrimethamine

                 

tablet, 25 mg

2

2

tablet

0.187

0.050

0.119

0.084

0.017

0.062

tinidazole

                 

tablet, 2 g*

-

-

tablet

-

-

-

-

n/a

n/a

tablet, 500 mg

4

3

tablet

0.058

0.012

0.016

0.014

n/a

0.663

Antiviral medicines

                 

aciclovir

                 

cream, 5%

5

4

gram

0.936

0.026

0.102

0.041

0.409

1.048

powder for injection, 250 mg (as sodium salt)

7

5

vial

14.286

0.170

2.000

1.882

1.457

4.133

tablet, 200 mg

16

12

tablet

0.435

0.025

0.045

0.031

0.086

0.576

tablet, 400 mg

11

6

tablet

0.350

0.048

0.086

0.059

n/a

n/a

tablet, 800 mg

10

6

tablet

1.370

0.098

0.366

0.180

n/a

1.818

cidofovir

                 

IV infusion, 75 mg/ml in 5-ml vial*

-

-

vial

-

-

-

-

n/a

117.572

famciclovir

                 

tablet, 125 mg*

-

-

tablet

-

-

-

-

n/a

2.349

tablet, 250 mg*

-

-

tablet

-

-

-

-

n/a

4.744

tablet, 500 mg*

-

-

tablet

-

-

-

-

n/a

n/a

foscarnet sodium

                 

IV infusion, 24 mg/ml*

-

-

ml

-

-

-

-

n/a

0.122

ganciclovir

                 

capsule, 250 mg*

-

-

capsule

-

-

-

-

n/a

n/a

capsule, 500 mg*

-

-

capsule

-

-

-

-

n/a

n/a

powder for IV infusion, 500 mg in vial

1

1

vial

42.520

42.520

42.520

42.520

17.337

19.990

imiquimod

                 

cream, 5%*

-

-

gram

-

-

-

-

n/a

n/a

podofilox

                 

cream, 0.15%, 5 g tube*

-

-

tube

-

-

-

-

n/a

13.036

solution or gel, 0.5%*

-

-

ml

-

-

-

-

n/a

8.379

podophyllum resin

                 

solution, 10 - 25%*

-

-

ml

-

-

-

-

n/a

n/a

valacyclovir

                 

tablet, 500 mg*

-

-

tablet

-

-

-

-

n/a

1.745

valganciclovir

                 

tablet, 450 mg*

-

-

tablet

-

-

-

-

n/a

21.630

abacavir (ABC)

                 

syrup, 20 mg/ml

1

1

ml

0.131

0.131

0.131

0.131

n/a

0.253

tablet, 300 mg

3

3

tablet

2.962

1.018

1.215

1.116

n/a

3.914

atazanavir (ATV)

                 

capsule, 200 mg*

-

-

capsule

-

-

-

-

n/a

7.500

didanosine (ddI)

                 

buffered chewable tablet, 100 mg

5

4

tablet

0.271

0.024

0.191

0.165

0.317

1.097

buffered chewable tablet, 25 mg

3

3

tablet

0.117

0.090

0.103

0.097

n/a

0.274

buffered chewable tablet, 50 mg

2

2

tablet

0.158

0.136

0.147

0.141

n/a

0.622

syrup, 2 g

1

1

ml

0.088

0.088

0.088

0.088

n/a

21.949

unbuffered enteric coated capsule, 125 mg*

-

-

capsule

-

-

-

-

n/a

1.623

unbuffered enteric coated capsule, 250 mg

3

3

capsule

0.557

0.430

0.543

0.486

n/a

3.432

unbuffered enteric coated capsule, 400 mg

2

2

capsule

0.764

0.543

0.653

0.598

n/a

5.401

efavirenz (EFZ)

                 

capsule, 100 mg

2

2

capsule

1.001

0.231

0.616

0.424

n/a

1.450

capsule, 200 mg

5

4

capsule

0.463

0.188

0.421

0.399

n/a

2.982

capsule, 50 mg

1

1

capsule

0.116

0.116

0.116

0.116

n/a

0.725

oral solution, 150 mg/5 ml

1

1

ml

0.094

0.094

0.094

0.094

n/a

n/a

tablet, 600 mg

5

3

tablet

1.312

0.950

1.189

1.003

2.182

9.165

emtricitabine (FTC)

                 

capsule, 200 mg*

-

-

capsule

-

-

-

-

n/a

n/a

indinavir (IDV)

                 

capsule, 200 mg (as sulphate)

2

2

capsule

0.170

0.137

0.153

0.145

n/a

0.754

capsule, 333 mg (as sulphate)*

-

-

capsule

-

-

-

-

n/a

n/a

capsule, 400 mg (as sulphate)

5

4

capsule

1.058

0.002

0.294

0.274

0.404

1.509

lamivudine (3TC)

                 

oral solution, 50 mg/5 ml

3

3

ml

0.028

0.021

0.025

0.023

0.035

0.032

tablet, 150 mg

10

6

capsule/tablet

0.398

0.094

0.118

0.097

0.237

2.476

tablet, 300 mg*

-

-

capsule/tablet

-

-

-

-

n/a

4.952

lopinavir+ritonavir (LPV/r)

                 

capsule, 133.3+33.3 mg*

-

-

capsule

-

-

-

-

n/a

2.087

oral solution, 400 mg+100 mg/5 ml*

-

-

ml

-

-

-

-

n/a

1.252

nelfinavir (NFV)

                 

oral powder, 50 mg/g

1

1

gram

0.243

0.243

0.243

0.243

n/a

0.354

tablet, 250 mg

4

4

tablet

0.921

0.290

0.480

0.405

0.611

1.132

nevirapine (NVP)

                 

syrup, 50 mg/5 ml

4

3

ml

0.073

0.013

0.018

0.014

0.143

0.171

tablet, 200 mg

9

6

tablet

3.306

0.122

0.195

0.171

n/a

4.336

saquinavir (SQV)

                 

hard gel capsule, 200 mg

1

1

capsule

0.294

0.294

0.294

0.294

n/a

1.036

soft gel capsule, 200 mg*

-

-

capsule

-

-

-

-

n/a

0.733

stavudine (d4T)

                 

capsule, 15 mg

1

1

capsule

0.058

0.058

0.058

0.058

n/a

2.089

capsule, 20 mg

3

3

capsule

0.094

0.056

0.070

0.063

n/a

2.167

capsule, 30 mg

9

6

capsule

1.345

0.043

0.068

0.056

0.093

2.267

capsule, 40 mg

10

7

capsule

1.427

0.055

0.075

0.065

0.182

2.343

syrup, 1 mg/ml

2

2

ml

0.048

0.011

0.029

0.020

n/a

0.095

tenofovir (TDF)

                 

tablet, 300 mg*

-

-

tablet

-

-

-

-

n/a

9.970

zalcitabine (ddC)

                 

tablet, 0.375 mg

1

1

tablet

0.251

0.251

0.251

0.251

n/a

n/a

tablet, 0.75 mg

2

2

tablet

0.865

0.425

0.645

0.535

n/a

1.393

zidovudine (AZT or ZDV)

                 

oral solution, 50 mg/5 ml

6

5

ml

0.300

0.016

0.025

0.021

0.015

0.060

solution for IV infusion/injection, 10 mg/ml in 20-ml vial

2

2

vial

41.000

5.000

23.000

14.000

1.443

6.474

tablet/capsule, 100 mg

9

8

capsule/tablet

0.617

0.076

0.140

0.115

0.114

0.659

tablet/capsule, 250 mg

5

5

capsule/tablet

1.450

0.315

0.360

0.332

n/a

1.643

tablet/capsule, 300 mg

10

6

tablet/capsule

0.475

0.005

0.250

0.218

n/a

1.972

Antiviral medicines - Antiretrovirals (combinations)

                 

3TC+AZT

                 

tablet, 150+300 mg

9

6

tablet

2.951

0.007

0.313

0.271

0.471

5.014

3TC+d4T

                 

tablet, 150+30 mg

3

2

tablet

0.174

0.107

0.158

0.139

n/a

n/a

tablet, 150+40 mg

5

2

tablet

0.267

0.117

0.175

0.159

n/a

n/a

3TC+d4T+NVP

                 

tablet, 150+30+200 mg

7

4

tablet

0.650

0.237

0.317

0.264

n/a

n/a

tablet, 150+40+200 mg

7

4

tablet

0.650

0.246

0.358

0.289

n/a

n/a

ABC+3TC

                 

tablet, 600+150 mg*

-

-

tablet

-

-

-

-

n/a

n/a

ABC+3TC+ZDV

                 

tablet, 300+150+300 mg

2

2

tablet

1.700

1.683

1.692

1.687

n/a

8.414

AZT+3TC+NVP

                 

tablet, 300+150+200 mg

2

2

tablet

0.500

0.452

0.476

0.464

n/a

n/a

FTC+TDF

                 

tablet, 200+300 mg*

-

-

tablet

-

-

-

-

n/a

n/a

 

* No price information; n/a - not available.

1 Please visit http://www.stoptb.org/gdf/ for a comprehensive list of TB medicines and pricing strategies


TABLE 2. ANTINEOPLASTIC MEDICINES

 

Manufacturer

Indicative price, US$

List prices, US$

Cytotoxic medicines

No. of manufacturers

No. of countries

unit

max

min

median

25th perc

Brazil

Spain

bleomycin

                 

powder for injection, 15 mg (as sulfate) in vial

5

4

vial

21.000

12.429

20.000

18.000

22.515

11.158

calcium folinate (leucovorin)

                 

injection, 3 mg/ml in 10-ml ampoule*

-

-

ampoule

-

-

-

-

n/a

n/a

tablet, 15 mg

4

4

tablet

3.799

0.014

1.047

0.328

n/a

0.582

doxorubicine HCl

                 

powder for injection, 10 mg in 5-ml vial

6

4

vial

25.780

2.940

4.591

3.375

3.196

5.836

powder for injection, 50 mg in 25-ml vial

5

4

vial

120.760

10.660

18.159

15.000

14.739

23.008

etoposide

                 

capsule, 100 mg

1

1

capsule

10.000

10.000

10.000

10.000

n/a

9.264

injection, 20 mg/ml in 5-ml ampoule

7

5

ampoule

33.921

1.723

6.000

3.857

2.921

6.607

liposomal doxorubicine HCl

                 

conc. for IV infusion, 2 mg/ml in vial*

-

-

vial

-

-

-

-

n/a

38.192

methotrexate

                 

injection, 25 mg/ml (as sodium salt) in 2-ml vial

3

3

vial

18.100

1.400

1.800

1.600

2.062

1.443

powder for injection, 50 mg (as sodium salt) in 2-ml vial

3

3

vial

4.310

2.000

3.360

2.680

n/a

2.989

tablet, 2.5 mg

5

4

tablet

0.188

0.034

0.070

0.065

n/a

0.043

vinblastine

                 

powder for injection, 10 mg (sulfate) in 10-ml vial

4

3

vial

14.260

1.400

5.254

3.281

11.684

5.170

vincristine

                 

powder for injection, 1 mg (sulfate) in 1-ml vial

3

2

vial

2.000

1.550

1.600

1.573

2.405

4.024

powder for injection, 5 mg (sulfate) in vial

1

1

vial

4.500

4.500

4.500

4.500

2.405

8.118

vinorelbine

                 

injection concentrate, 10 mg/ml in vial

2

2

ml

23.230

19.500

21.365

20.433

143.086

16.201

 

* No price information; n/a - not available.


TABLE 3. PSYCHOTHERAPEUTIC MEDICINES

 

Manufacturer

Indicative price, US$

List prices, US$

Medicines used in depressive disorders

No. of manufacturers

No. of countries

unit

max

min

median

25th perc

Brazil

Spain

amitriptyline

                 

tablet, 25 mg (as hydrochloride)

5

5

tablet

0.078

0.003

0.007

0.004

0.010

0.026

fluoxetine

                 

tablet, 20 mg

8

6

tablet

0.626

0.015

0.073

0.044

0.034

0.329

Medicines used in generalized anxiety and sleep disorders

diazepam

                 

injection, 5 mg/ml in 2-ml ampoule

5

5

ampoule

0.298

0.090

0.120

0.110

n/a

n/a

tablet, 5 mg

6

6

tablet

0.020

0.002

0.004

0.003

n/a

0.016

lorazepam

                 

injection, 4 mg/ml in 1-ml ampoule

1

1

ampoule

0.008

0.008

0.008

0.008

n/a

n/a

tablet, 1 mg

2

2

tablet

0.047

0.006

0.027

0.016

n/a

0.022

methotrimepazine/levomepromazine

                 

powder for injection, 10 mg (sulfate) in 10-ml vial

2

2

tablet

0.108

0.033

0.070

0.052

n/a

0.229

tablet, 25 mg*

-

-

tablet

-

-

-

-

0.038

0.047

Medicines used in substance dependence programmes

methadone HCl

                 

oral solution, 10 mg/5 ml*

-

-

ml

-

-

-

-

n/a

n/a

oral solution, 5 mg/5 ml

1

1

ml

0.020

0.020

0.020

0.020

n/a

n/a

powder for oral concentrate, 10 mg/ml*

-

-

ml

-

-

-

-

n/a

n/a

powder for oral concentrate, 5 mg/ml*

-

-

ml

-

-

-

-

n/a

n/a

tablet, 5 mg*

-

-

tablet

-

-

-

-

n/a

0.044

buprenorphine

                 

sublingual tablet, 2 mg (hydrochloride)*

-

-

tablet

-

-

-

-

n/a

0.280

sublingual tablet, 8 mg (hydrochloride)*

-

-

tablet

-

-

-

-

n/a

n/a

naltrexone HCl

                 

tablet, 50 mg

2

2

tablet

1.388

0.969

1.178

1.074

n/a

1.911

 

* No price information; n/a - not available.


TABLE 4. ANALGESICS

 

Manufacturer

Indicative price, US$

List prices, US$

Opioid analgesics

No. of manufacturers

No. of countries

unit

max

min

median

25th perc

Brazil

Spain

codeine

                 

tablet, 30 mg (phosphate)

3

3

tablet

0.062

0.033

0.036

0.034

0.232

0.079

morphine

                 

injection, 10 mg/ml (sulfate or HCl), in 1-ml ampoule

2

2

ampoule

0.439

0.307

0.373

0.340

0.495

0.240

oral solution, 10 mg/5 ml (sulfate or HCl)*

-

-

ml

-

-

-

-

n/a

0.130

tablet, modified release, 10 mg (sulfate)*

-

-

tablet

-

-

-

-

n/a

0.123

pethidine

                 

injection, 50 mg/ml (hydrochloride) in 1-ml ampoule

2

2

ampoule

0.390

0.360

0.375

0.368

0.344

n/a

injection, 50 mg/ml (hydrochloride) in 2-ml ampoule

4

4

ampoule

0.600

0.374

0.476

0.401

n/a

0.666

tablet, 100 mg*

-

-

tablet

-

-

-

-

n/a

n/a

tablet, 50 mg

1

1

tablet

0.130

0.130

0.130

0.130

n/a

n/a

 

* No price information; n/a - not available.


TABLE 5. GASTROINTESTINAL MEDICINES

 

Manufacturer

Indicative price, US$

List prices, US$

Antacids and other antiulcer medicines

No. of manufacturers

No. of countries

unit

max

min

median

25th perc

Brazil

Spain

omeprazole

                 

capsule, 10 mg

4

4

capsule

0.339

0.015

0.057

0.041

0.028

0.086

capsule, 20 mg

21

12

capsule

0.368

0.011

0.075

0.021

0.034

0.168

capsule, 40 mg

3

3

capsule

0.601

0.140

0.563

0.143

n/a

0.372

powder for injection, 40 mg (as sodium salt) in vial

1

1

vial

3.000

3.000

3.000

3.000

1.371

7.282

powder for IV infusion, 40 mg (as sodium salt) in vial

1

1

vial

3.000

3.000

3.000

3.000

n/a

n/a

Antiemetic medicines

                 

dimenhydrinate

                 

tablet, 50 mg

5

5

tablet

0.041

0.005

0.009

0.008

n/a

0.199

metoclopramide

                 

injection 5 mg/ml in 2-ml ampoule

6

3

ampoule

0.200

0.041

0.103

0.065

0.062

0.171

tablet, 10 mg (as hydrochloride)

6

6

tablet

0.072

0.004

0.008

0.005

0.005

0.038

prochlorperazine

                 

injection, 12.5 mg/ml

1

1

ml

0.359

0.359

0.359

0.359

n/a

n/a

tablet, 10 mg*

-

-

tablet

-

-

-

-

n/a

n/a

tablet, 5 mg

1

1

tablet

0.008

0.008

0.008

0.008

n/a

n/a

promethazine

                 

elixir or syrup, 5 mg/5 ml (HCl)

3

3

ml

0.008

0.005

0.006

0.005

n/a

n/a

injection, 25 mg/ml (hydrochloride) in 2-ml ampoule

3

3

ampoule

0.200

0.176

0.188

0.182

n/a

n/a

tablet, 10 mg

1

1

tablet

0.008

0.008

0.008

0.008

n/a

n/a

tablet, 25 mg

3

3

tablet

0.010

0.004

0.008

0.006

n/a

n/a

Laxatives

                 

docusate sodium

                 

capsule, 100 mg*

-

-

capsule

-

-

-

-

n/a

0.063

paediatric oral solution, 12.5 mg/5 ml*

-

-

ml

-

-

-

-

n/a

n/a

senna

                 

capsule, 7.5 mg

1

1

capsule

0.017

0.017

0.017

0.017

n/a

n/a

 

* No price information; n/a - not available.


5.2 HIV Test Kits - Simple/Rapid, EIA and Confirmatory Assays1

SIMPLE/RAPID TEST KITS

Assay Name
(Manufacturer)

Company Order Code*

Test per Kit

Shelf Life/Storage Temp (°C)

HIV Type2

Assay Type/ Antigen Type

Sample Type

Equipment3

WHO Report4

Indicative Price5

Advanced Quality™
Rapid HIV Test
(InTec Products)

ITP02002-TC40

40

18 months/2°-30°

HIV
1+2

lateral flow/recombinant proteins

serum/plasma whole blood

G

12 & 16

US$0.80-$1.20

Bionor HIV-1&2
(Bionor)

 

40
200

6 months/2°-8°C

HIV
1+2

magnetic beads/synthetic peptides

serum/plasma whole blood

C, D, E, G Bionor Testing Station (US$1000)

11

US$2.50

Capillus™ HIV-1/HIV-2
(Trinity Biotech)

6048G

100

9 months/2°-8°

HIV
1+2

agglutination/recombinant proteins

serum/plasma whole blood

G

12

US$2.20

Determine™ HIV-1/2
Serum/Plasma Assay
(Abbott Diagnostics)

7D23-13

100

6-9 months/2°-30°

HIV
1+2

lateral flow/recombinant protein, synthetic peptide

serum/plasma whole blood

D, G

12

US$1.20

Determine™ HIV-1/2
Whole Blood Assay
(Abbott Diagnostics)

7D23-33

100

             

Diagnostic Kit for HIV (1+2) Antibody
(Colloidal Gold)
(Shanghai Kehua)

KH-R-02

50

15 months/4°-30°

HIV
1+2

lateral flow/recombinant protein, synthetic peptide

serum/plasma whole blood

D, G

14

US$0.60

DoubleCheck
HIV 1&2
(Orgenics)

60332000

40

15 months/4°-8°

HIV
1+2

lateral flow/recombinant proteins, synthetic peptides

serum/plasma

G

11

US$2.00

First Response™
HIV 1-2-0 Card Test
(Premier Medical Corp)

I05FRC30

30

15 months/2°-30°

HIV
1+2

lateral flow/recombinant proteins

serum/plasma whole blood

D, G

12

US$1.15

Genedia® HIV 1/2
Rapid 3.0
(Green Cross Medical Science)

F3302

30

14 months/2°-30°

HIV1
1+2

lateral flow/recombinant proteins

serum/plasma whole blood

D, G

14

US$0.93-1.15

Genie II HIV-1/HIV-2
(Bio-Rad Laboratories)

72323

40

12 months/2°-8°

HIV
1+2

lateral flow/recombinant proteins, synthetic peptides

serum/plasma

D, G

14

US$2.55

HIV 1/2 Stat-Pak
(Chembio Diagnostics)

HIV101
HIV133

20
Bulk

18 months/8°-30°

HIV
1+2

lateral flow/synthetic peptides

serum/plasma whole blood

G

14 & 16

US$1.45

HIV 1/2 Stat-Pak
Dipstick
(Chembio Diagnostics)

HIV301
HIV333

20
Bulk

18 months/8°-30°

HIV
1+2

lateral flow dipstick/synthetic peptides

serum/plasma whole blood

C, G

16

US$1.15

HIV Tridot
(J Mitra & Co)

IR130050
IR130100
IR130200

50
100
200

10 months/4°-8°

HIV 1
HIV 2

flow through/recombinant proteins

serum/plasma

G

11

US$2.00

 

* Company order code may vary from country to country

1 This is a list of HIV test kits evaluated by WHO and which are still commercially available. Therefore, the list may include test kits not currently on the UN Bulk Procurement Scheme.

2 Assays denoted as HIV 1 HIV 2 are capable of discrimination between HIV-1 and HIV-2, those denoted HIV 1+2 are not capable of discrimination

3 Equipment Requirements - A: ELISA reader, B: ELISA washer, C: Consumables, D: Pipette, E: Power supply, F: For large volume testing more than 40 samples daily, G: For small volume testing 1 to 40 samples daily

4 Report numbers in italics are currently in publication

5 Indicative pricing only, price stated by the company in original WHO test kit evaluation


Assay Name
(Manufacturer)

Company Order Code*

Test per Kit

Shelf Life/Storage Temp (°C)

HIV Type1

Assay Type/ Antigen Type

Sample Type

Equipment2

WHO Report3

Indicative Price4

Immunocomb® II
BiSpot
HIV 1 & 2
(Orgenics)

60432002

36

15 months/4°-8°

HIV 1
HIV 2

dipstick/synthetic peptides

serum/plasma

D, G

9

US$1.70

Instant Chek™ HIV
1+2 Rapid Test
(EY Laboratories)

8-1003-40
8-1003-100

40
100

16 months/4°-25°

HIV 1+2

lateral flow/recombinant protein

serum/plasma whole blood

G

14

US$1.00

OraQuick® HIV-1/2 - Rapid HIV-1/2
Antibody Test
(OraSure Technologies)

5X4-0012
5X4-0010

100
500

8 months/2°-30°

HIV 1+2

lateral flow/synthetic peptides

serum/plasma whole blood oral fluid

G

14 & 18

US$4.00

Retrocheck HIV
(Qualpro Diagnostics)
also marketed Core™
HIV 1&2
(Core Diagnostics)

40501050
40501100

50
100

24 months/4°-30°

HIV 1+21

lateral flow/recombinant protein, synthetic peptides

serum/plasma whole blood

G

16

US$0.75
US$0.70

SD BIOLINE HIV-1/2 3.0
(Standard Diagnostics)

03FK10

30

16 months/2°-30°

HIV 1
HIV 2

lateral flow/recombinant proteins

serum/plasma whole blood

D, G

14

US$1.10

Serocard HIV
(Trinity Biotech)

1200100

40

15 months/2°-8°

HIV 1+2

lateral flow/synthetic peptides

serum/plasma whole blood

G

11

US$4.00

Serodia® HIV
(Fujirebio)

224557
224564

100
220

12 months/2°-10°

HIV 1

agglutination/recombinant proteins

serum/plasma

C, D, G

1

US$0.88

Serodia® HIV-1/2
(Fujirebio)

220658
226063

100
220

12 months/2°-10°

HIV 1+2

agglutination/recombinant proteins

serum/plasma

C, D, G

8

US$2.80

Uni-Gold™
HIV-1/HIV-2
(Trinity Biotech)

1206502

20

9 months/2°-27°

HIV 1+2

lateral flow/recombinant proteins

serum/plasma whole blood

G

12

US$2.34

 

* Company order code may vary from country to country

1 Assays denoted as HIV 1 HIV 2 are capable of discrimination between HIV-1 and HIV-2, those denoted HIV 1+2 are not capable of discrimination

2 Equipment Requirements - A: ELISA reader, B: ELISA washer, C: Consumables, D: Pipette, E: Power supply, F: For large volume testing more than 40 samples daily, G: For small volume testing 1 to 40 samples daily

3 Report numbers in italics are currently in publication

4 Indicative pricing only, price stated by the company in original WHO test kit evaluation


EIA TEST KITS

Assay Name
(Manufacturer)

Company Order Code*

Test per Kit

Shelf Life/Storage Temp (°C)

HIV Type1

Antigen Type/Wavelength

Sample Type

Equipment2

WHO Report3

Indicative Price4

Anti-HIV 1+2 Antibodies ELISA Diagnostics Kit
(Shanghai Kehua)

KH-T-10

96

5 months/2°-8°

HIV 1+2

recombinant proteins, synthetic peptides/450/620nm

serum/plasma

A, B, C, D, E, F

17

US$0.27

Enzygnost Anti-HIV1/2 Plus
(Dade Behring)
Reagent Kit

OQFK135
OQFK215
OUVP175

192
960

12 months/2°-8°

HIV 1+2 O

recombinant proteins/450/650nm

serum/plasma

A, B, C, D, E, F

11

US$1.00 Gratis

Genedia® HIV Ag-Ab
ELISA
(Green Cross)

D1305

480

15 months2°-8°

HIV 1+2 O HIV Ag

recombinant proteins synthetic peptides monoclonal antibody/450/620nm

serum/plasma

A, B, C, D, E, F

15

US$0.35

Genscreen® Plus HIV
Ag-Ab
(BioRad Laboratories)

72375
72376

96
480

9 months/2°-8°

HIV 1+2 O HIV Ag

recombinant proteins synthetic peptides monocolonal antibody/450/620nm

serum/plasma

A, B, C, D, E, F

15

US$0.35

HIV EIA
(AniLabsystems OY)

6111011
6111012
6111013

96
480
960

12 months/4°-8°

HIV 1+2

synthetic peptides/450nm

serum/plasma

A, B, C, D, E, F

10

US$0.60

IMx HIV-1/HIV-2
3rd generation Plus
(Abbott Diagnostics)

 

100

3 months/2°-8°

HIV 1+2

recombinant proteins synthetic peptides

serum/plasma

A, B, C, D, E, F IMx Instrumentation

11

US$3.00

Murex HIV Ag/Ab Combination
(Abbott/Murex)

L/N7G79-01
L/N7G79-02

96
480

6 months/2°-8°

HIV 1+2 O HIV Ag

recombinant proteins synthetic peptides, monoclonal antibody/450/620nm

serum/plasma

A, B, C, D, E, F

15

US$1.20
US$0.80

UBI HIV 1/2 EIA
(United Biomedical Inc)

680328

192

14 months/2°-8°

HIV
1+2

synthetic peptides/492 492/620-690

serum/plasma

A, B, C, D, E, F

9

US$1.00

Vironostika Uni-Form II plus O
(bioMérieux bv)

284017
284018

192
576

12 months/2°-8°

HIV
1+2 O

recombinant proteins synthetic peptides/450/620nm

serum/plasma

A, B, C, D, E, F

11

US$1.50

Vironostika® HIV
Uni-Form II Ag/Ab
(bioMérieux bv)

285046
285047

192
576

9 months/2°-8°

HIV 1+2 O HIV Ag

recombinant proteins synthetic peptides, monoclonal antibody/450/620nm

serum/plasma

A, B, C, D, E, F

15

US$1.48

 

* Company order code may vary from country to country

1 Assays denoted as HIV 1 HIV 2 are capable of discrimination between HIV-1 and HIV-2, those denoted HIV 1+2 are not capable of discrimination

2 Equipment Requirements - A: ELISA reader, B: ELISA washer, C: Consumables, D: Pipette, E: Power supply, F: For large volume testing more than 40 samples daily, G: For small volume testing 1 to 40 samples daily

3 Report numbers in italics are currently in publication

4 Indicative pricing only, price stated by the company in original WHO test kit evaluation


CONFIRMATORY TEST KITS

Assay Name
(Manufacturer)

Company Order Code*

Test per Kit

Shelf Life/Storage Temp (°C)

HIV Type1

Assay Type/Antigen Type

Sample Type

Equipment2

WHO Report3

Indicative Price4

Genelabs Diagnostics
HIV BLOT 2.2
(M P Biomedicals Asia Pacific)

11031-036

36

15 months/2°-8°

HIV 1
HIV 2

Western blot/viral lysate, synthetic peptide

serum/plasma

C, D, E

N/A

US$10.97

INNO-LIA™ HIV I/II
SCORE
(Innogenetics)

80540

20

?/2°-8°

HIV 1
HIV 2

line immunoassay/recombinant proteins, synthetic peptides

serum/plasma

C, D, E

N/A

15.50

PEPTI-LAV 1-2
(Bio-Rad Laboratories)

72253

10

9 months/2°-8°

HIV 1
HIV 2

line immunoassay/synthetic peptides

serum/plasma

C, D, E

N/A

15.00

NEW LAV BLOT I
(Bio-Rad Laboratories)

72251

18

9 months/2°-8°

HIV 1

Western blot/viral lysate

serum/plasma

D, E

N/A

13.00

NEW LAV BLOT II
(Bio-Rad Laboratories)

72252

18

9 months/2°-8°

HIV 2

Western blot/viral lysate

serum/plasma

D, E

N/A

13.00

 

* Company order code may vary from country to country

1 Assays denoted as HIV 1 HIV 2 are capable of discrimination between HIV-1 and HIV-2, those denoted HIV 1+2 are not capable of discrimination

2 Equipment Requirements - A: ELISA reader, B: ELISA washer, C: Consumables, D: Pipette, E: Power supply, F: For large volume testing more than 40 samples daily, G: For small volume testing 1 to 40 samples daily

3 Report numbers in italics are currently in publication

4 Indicative pricing only, price stated by the company in original WHO test kit evaluation

N/A - Not applicable

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 29, 2018